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Background-—Cardiovascular diseases (CVDs) and stroke are the highest and third highest causes of death, respectively, in the
whole United States. It is well established that both long- and short-term exposure to particulate air pollution (particulate matter
with diameters <2.5 lm [PM2.5]) increases the risks of both CVD and stroke mortality.
Methods and Results-—We combined county-level data for CVD and stroke mortality, and prevalence of hypertension and obesity,
with spatial patterns of PM2.5 and ozone in a cross-sectional ecological study. We found signiﬁcant positive associations between
both CVD (b=15.4, P<0.001) and stroke (b=2.7, P<0.001) mortality with PM2.5. Ozone had signiﬁcant link with just CVD
(b=1372.1, P<0.001). Once poverty, ethnicity, and education were taken into account, there were still signiﬁcant positive
associations between PM2.5 and both CVD (b=1.2, P<0.001) and stroke (b=1.1, P<0.001) mortality. Moreover, the association
between CVD and ozone remained after adjustment for these factors (b=21.8, P<0.001). PM2.5 and ozone were independent risk
factors. The impact of PM2.5 on CVD and stroke mortality was strongly dependent on the prevalence of obesity. Hypertension
partially mediated the associations of PM2.5 and mortality from CVD and stroke.
Conclusions-—There was a spatial association between PM2.5 exposure and the leading causes of death and disability in United
States. The effect of PM2.5 was considerably greater in areas where obesity is more prevalent. Hypertension is a possible mediator
of the association of PM2.5 and both CVD and stroke. ( J Am Heart Assoc. 2018;7:e008006. DOI: 10.1161/JAHA.117.008006.)
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A ccording to the latest report of American Heart Asso-ciation, each year 17.3 million people die globally of
cardiovascular disease (CVD), accounting for 30% of global
mortality.1 Stroke is the second most common cause of
death, and third most important cause of disability world-
wide.2 In the United States in 2015, CVD was the leading
cause of death, accounting for 864 000 deaths.3 Apart from
genetic and lifestyle risk factors, exposure to air pollution,
speciﬁcally ﬁne particulate matter (PM; particle size <2.5 lm
[PM2.5]), has been suggested to be linked with CVD and
stroke mortality.4,5
Although considerable effort has been directed at control-
ling and monitoring ambient concentrations of PM for the past
30 years, and these efforts have been largely successful,
levels of air pollution in larger US cities still occasionally
exceed by an order of magnitude the recommended safe
levels of PM2.5 pollution.
6 Worldwide, it has been suggested
that particulate air pollution is responsible for >3 million
deaths every year.5,7 PM2.5 can be deposited in the upper and
lower airways, and because of its small size, it can reach more
deeply into the lungs and circulation. Therefore, it has been
implicated in deleterious outcomes, such as CVD, stroke, and
endothelial dysfunction.5,8 In the case of endothelial dysfunc-
tion, a previous study suggested that PM2.5 can rapidly exert
its harmful impacts on blood pressure (BP) within just 2 hours
of exposure.9 Moreover, in 36 US metropolitan areas, among
postmenopausal women, long-term exposure to PM was
linked with the incidence of CVD and death.10
The American Heart Association already concluded in 2004
that PM contributes to cardiovascular morbidity and mortality,
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and this opinion was reinforced by a comprehensive review,
meta-analysis, and updated statement in 2009.5 Neverthe-
less, since that time, there have been several large studies
that have failed to ﬁnd any association between PM2.5 and the
risk of CVD.11–15 For example, in the multicenter ESCAPE
(European Study of Cohorts for Air Pollution Effects), which
involved 367 383 participants, they reported that in a joint
analysis of data from 22 European cohorts, most hazard ratios
for the association of long-term exposure to air pollutants
with mortality from overall CVD and with speciﬁc CVDs were
113 (ie, there was no elevated risk).
The data about links of stroke to air pollution levels are also
inconsistent. In detail, some studies have reported a positive
association between PM2.5 and the risk of stroke.
16–21 For
instance, across 204 US counties, a 10-lg/m3 increase in
short-term PM2.5 concentration was associated with a 0.8%
increased chance of hospital admission for stroke.21 However,
other studies failed to ﬁnd such an association.22–25 For
example, a time-stratiﬁed case-crossover was used to assess
the associations between short-term outdoor PM2.5 and
emergency department admissions for stroke among elderly
people (≥65 years of age) in Canada, and no association
between outdoor measures of air pollution and all stroke visits
was detected.22 Results from French National Program on Air
Pollution Health Effects, which was conducted between 1998
and 2003, also found no association between short-term
PM2.5 exposure and stroke.
25 In case of the heterogeneity and
controversy between current studies, previous meta-analyses
have also reported that the direction of the association
between PM2.5 levels and the risk of different types of stroke
is not consistent across studies.26–28 These meta-analyses
have suggested this high heterogeneity may be attributable to
differences in the deﬁnition of outcomes, different techniques
for measuring the PM2.5, using different confounders in the
models for evaluation, and applying different databases with
varying levels of socioeconomic factors (income, education,
and ethnicity) status.28
In their comprehensive review of the association between
particulate air pollution and CVD, Brook and colleagues5
highlighted several key areas in need of future study. First,
they noted that levels of PM2.5 might covary with other levels
of air pollutions and, hence, the causal factor driving the CVD
effects might not be PM2.5 but these covariates. This could
explain why more recent large cohorts have failed to detect
associations (previously reviewed). One potential covariate is
ozone. A recent meta-analysis and systematic review drew
attention to the paucity of studies about the association
between long-term exposure to ozone and mortality.29 Brook
et al5 also concluded that there was indicative evidence that
obese individuals may be a susceptible population at greater
risk for cardiovascular events due to PM2.5 exposure, and that
“This is a tremendously important public health issue to
corroborate because of the enormous and growing prevalence
of obesity worldwide”.5 A cross-sectional study of Chinese
adults suggested that being overweight or obese may
enhance the effect of air pollution on prevalence of CVD
and stroke.30
With respect to the unclear mechanism of any impact of
PM2.5 on CVD and stroke pathological characteristics, an
important question is, if it is the causal agent, whether PM2.5
induces deleterious effects directly, or via impacts on other
factors (such as hypertension). These complexities in the
associations can be clariﬁed using mediation analysis31; in
particular, use of the counterfactual framework (or Neyman-
Rubin model) in mediation analysis allows unbiased esti-
mates of direct and indirect effects to be obtained.31,32 In
the present article, in the light of recent reports of no
signiﬁcant association, we aimed to determine whether there
is an association between the long-term spatial variation in
both PM2.5 and ozone levels across the mainland United
States and the spatial patterns of mortality from CVD and
stroke, and the prevalence of hypertension. Second, we
evaluated the impact of varying levels of obesity prevalence
on the relationship between long-term PM2.5 exposure and
mortality from CVD and stroke. Third, we aimed to assess
whether hypertension mediates any association between
long-term PM2.5 and mortality from CVD and stroke. We
accomplished this by matching data on the disease mortal-
ities and prevalence from the US Centers for Disease
Clinical Perspective
What Is New?
• It has been suggested that particulate air pollution (partic-
ulate matter with diameters <2.5 lm) increases the risk of
cardiovascular disease and stroke. However, the evidence is
mixed and the possible interaction with other factors, such
as ozone levels and obesity, are unclear.
• We explored spatial variation in particulate matter with
diameters <2.5 lm, ozone, hypertension, obesity, and the
mortality from cardiovascular disease and stroke, across the
mainland United States.
• We found independent associations between particulate
matter with diameters <2.5 lm and ozone on cardiovascu-
lar disease and stroke mortality that were mediated, at least
in part, via hypertension.
• Effects of particulate matter with diameters <2.5 lm were
greater in areas where there were more individuals with
obesity.
What Are the Clinical Implications?
• If these associations are causal, then avoiding high levels of
air pollution may reduce the risk of cardiovascular disease
and stroke, particularly in individuals with obesity.
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Control and Prevention (CDC; between 2011 and 2013) with
data on the spatial patterns of air pollution (PM2.5;
2003–2011) from the US National Aeronautics and Space
Administration.
Methods
Mortality and Prevalence
The data, analytic methods, and study materials will be/have
been made available to other researchers for purposes of
reproducing the results or replicating the procedure.33 We
used data on mortality rate (per 100 000 individuals) for CVD
and stroke (between 2011 and 2013, aged >35 years) and
prevalence of obesity from the publicly available databases
compiled by the CDC (http://www.cdc.gov). Annual CVD
mortality was deﬁned as the number of deaths per
100 000 person-years attributable to circulatory causes
(International Statistical Classiﬁcation of Diseases, Tenth
Revision, codes I00–I99). Codes I60 to I69 were considered
for cerebrovascular diseases. We obtained data on prevalence
of hypertension (hypertension was deﬁned as systolic BP of at
least 140 mm Hg, self-reported use of antihypertensive
treatment, or both) from county health rankings and road-
maps organization (http://www.countyhealthrankings.org).
These data were estimated on the basis of the National
Health and Nutrition Examination Survey in ﬁve 2-year waves
from 1999 to 2008, including 26 349 adults aged ≥30 years,
and the Behavioral Risk Factor Surveillance System from
1997 to 2009, including 1 283 722 adults aged ≥30 years.
This is a collaboration of the Robert Wood Johnson Foundation
and the University of Wisconsin Population Health Institute.
The organization compiles data at the county level from
several national government sources, including health behav-
iors, clinical care, social and economic factors, and aspects of
the physical environment; preparation, deﬁnition, download,
and sorting of data on prevalence of obesity, poverty, and
ethnicity have been explained elsewhere.34 Brieﬂy, the
prevalence of obesity in this database was estimated using
data from the CDC Behavioral Risk Factor Surveillance
System, which is a monthly state-based telephone survey of
a nationally representative sample of adults aged >20 years
old. Because it is telephone based, it excludes individuals
living in care homes or those without a telephone. More than
400 000 individuals are contacted annually to take part in the
survey, which has been running since 1984. In the telephone
interview, individuals self-report their height and weight in
response to the questions “About how much do you weigh
without shoes?” and “About how tall are you without shoes?,”
which are then converted, if necessary, to kilograms and
meters, respectively, before calculating the body mass index
(BMI; kilograms per meter squared). A BMI >30 kg/m2 is then
classed as obese using the World Health Organization
standard for whites.35 This is applied independent of actual
ethnicity. Individuals normally overestimate their own height
and underestimate their own weight in a self-report
setting36,37 and, hence, these estimates are likely to be
conservative. Despite the small bias of 0.7 to 1.3 kg/m2,
validation studies conﬁrm a strong correlation between self-
reported and actual BMI.38,39 Obesity prevalence data in 2012
were available for 3143 counties or county equivalents from
the continental United States, reﬂecting a population of
170 million adults. A previous variogram analysis34 showed
that the county-level data are a suitable spatial scale at which
to seek disease associations for obesity prevalence. Previous
studies have used the same database to study factors
inﬂuencing obesity prevalence,40 links of obesity to restaurant
densities,41 and links of obesity and diabetic patients to
PM2.5.
42 Institutional review board approval was obtained by
CDC, and each subject signed informed consent. All the data
are already in the public domain from sites identiﬁed in the
main text.33
Particulate Air Pollution
Estimates of PM2.5 for each county were obtained for 2003
to 2011, as documented on CDC WONDER (http://wonde
r.cdc.gov), speciﬁcally ﬁle D80a. Reported measures are the
average daily estimates of PM2.5 over the 7-year interval in
micrograms per cubic meter (lg/m3). The values were
interpolated to the county level, from 10-km square spatial
area grids covering the 48 contiguous United States (not
including Alaska and Hawaii). Two sources of environmental
data were used as input to the surfacing algorithm, US
Environmental Protection Agency Air Quality System PM2.5
in situ data and US National Aeronautics and Space
Administration Moderate Resolution Imaging Spectrora-
diometer aerosol optical depth remotely sensed data. Data
on ozone were obtained from http://www.epa.gov, which is
the formal website for the US Environmental Protection
Agency. Ozone levels were only available for 801 of the
3111 counties.
Covariates
Data of county-level poverty (percentage in poverty and
average income), education, and ethnicity were obtained from
the US Census, 2010 census data (http://www.census.gov/
2010census), speciﬁcally ﬁles PVY01, PVY02, INC01, INCO2,
INCO3, IPE01, and RHI02. The distributions of ethnicity data
showed heteroscedasticity in the variance. We tried various
transformations to remove this, but none was completely
successful. The outcome of the ﬁnal analysis was robust to
the type of data transformation used.
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Statistical Analysis
We used univariate linear regression to investigate the
associations between mortality (CVD and stroke) and
prevalence (hypertension) data (dependent variables) with
the PM2.5 levels (independent variable) for each county
(identiﬁed by the federal information processing standard
code, which is a 5-digit code that allows counties and
county equivalent units to be uniquely identiﬁed). To assess
if the relationships were nonlinear, we included higher-order
polynomial terms into the regression model and tested if
they were signiﬁcant. In the absence of signiﬁcant higher-
order polynomials, we assumed the relationships were
linear. We then sought associations between these depen-
dent variables and the records of county-level poverty
(percentage in poverty), ethnicity (percentage black), and
education (percentage with bachelor’s degree or higher). All
data were checked for normality (Kolmogorov-Smirnov tests)
before analysis and, where necessary, were transformed
(with the use of log or arcsine transformation). These data
allowed us to adjust mortality (CVD and stroke) and
prevalence (hypertension) data at the county level for these
potential confounders (poverty, education, and ethnicity),
and then examine the associations of the adjusted levels to
PM2.5. For a subsample of the data (n=801 counties), we
estimated the association between ozone (independent) and
mortality from CVD and stroke and prevalence of the
hypertension in both the crude and adjusted model
(ethnicity, poverty, and education). We have also applied a
multiple linear regression to evaluate if ozone and PM2.5
were independent predictors of the mortality from CVD and
stroke and prevalence of the hypertension in both crude and
adjusted models (ethnicity, poverty, and education). Multi-
collinearity for the multiple linear regressions was assessed
with variance inﬂation factors at each step.43 Multicollinear-
ity was considered high when the variance inﬂation factor
was >10.43
We also quantiﬁed the impact of obesity on the link
between PM2.5 with CVD and stroke mortality by applying the
moderation model using the SPSS Macro developed by
Preacher and Hayes44; by applying this Macro, we could
simultaneously test the moderator impact of the variable of
interest, obesity, adjusting for the confounding factors.
Moreover, this approach allowed visualization of the impact
of each SD change in the potential moderators on the
relationship between independent and dependent variables.
We tested for the presence of an effect of obesity in both
crude and adjusted models (adjusted for ethnicity, poverty,
and education).
We assessed the total, direct, and indirect effects of PM2.5
on mortality from CVD and stroke, with hypertension as a
mediator, by using the counterfactual framework.31,32 In this
approach, the total effect can be decomposed into direct
effects (not mediated by hypertension) and indirect effects
(mediated via hypertension). The SPSS Macro developed by
Preacher and Hayes44 was used to evaluate the direct effect
and the indirect effect of PM2.5 on mortality from CVD and
stroke, with hypertension as mediator. A product-of-coefﬁ-
cients test was used because it has the potential to detect
signiﬁcant mediation effects in the absence of a signiﬁcant
intervention effect.45,46 Using single-mediator models, the
SPSS Macro was used to calculate all regression coefﬁcients
that were adjusted for baseline values. In brief, the Macro
generates output that includes the following steps. First, the
total effect (c coefﬁcient) of the intervention on the outcome
variable (eg, mortality from CVD and stroke) is estimated by
regression. Second, the action theory test is then used to
examine the effect of the intervention (PM2.5) on the
hypothesized mediators (a coefﬁcient and hypertension).
Third, the conceptual theory test examines the association
between changes in the hypothesized mediators and changes
in the dependent variables (ie, mortality from CVD and stroke;
b coefﬁcient). The program also estimates the direct (c0
coefﬁcient) and indirect (a9b product of coefﬁcients) effects.
Sobel’s test was used to test the signiﬁcance of the indirect
effect. The proportion of the mediation effect was calculated
using the following equation: (a9b)/(a9b+c).47 Full or
complete mediation is present when the total effect (the c
path) is signiﬁcant, the direct effect (the c0 path) is
nonsigniﬁcant, and a9b is signiﬁcant, whereas partial or
incomplete mediation is present when both the direct and
indirect effects were signiﬁcant. Inconsistent mediation is
present when neither the total nor the direct effect is
signiﬁcant, but a9b is signiﬁcant.47 SPSS software, version
11.5 (SPSS Inc, Chicago, IL) was used for statistical analysis.
P<0.05 was considered statistically signiﬁcant.
Results
Mean and SD for distribution of all of dependent and
independent variables and number of counties that each
variable covered are shown in Table 1. There was a positive
relationship between both crude level of CVD and stroke
mortality with the annual average level of PM2.5 (Table 2). The
b values that increase in the levels of PM2.5 air pollution by
5 lg/m3 would be associated with an increase in the
mortality from CVD by 77 people per 100 000 population
(21.2% increase on mean levels) and from stroke by 13.5
people per 100 000 population (16.9% increase on mean
levels). Also, prevalence of hypertension (percentage) had a
strong positive relationship with PM2.5. The b values suggest
that an increase in PM2.5 air pollution by 5 lg/m
3 would be
associated with a 4.3% increase in hypertension. In all 3
cases, the relationships were not improved by the addition of
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higher-order polynomial predictors, indicating the relation-
ships were not signiﬁcantly different from linear.
Overall mortality rates from CVD and stroke were greater
where there was more poverty (b=6.73 [95% conﬁdence
interval {CI}, 6.35–7.11] and b=1.08 [95% CI, 1.02–1.16],
respectively; both P<0.001), a higher proportion of blacks
(b=14.3 [95% CI, 13.0–15.7] and b=2.85 [95% CI, 2.58–3.11],
respectively; both P<0.001), and a less educated population
(b=4.88 [95% CI, 5.16 to 4.60] and b=0.71 [95% CI,
0.77 to 0.65], respectively; both P<0.001). With respect
to hypertension, we found that counties with higher levels of
poverty (b=0.4; 95% CI, 0.38–0.41; P<0.001), a greater
proportion of blacks (b=1.3; 95% CI, 1.11–1.4; P<0.001), and
less educated populations (b=0.23; 95% CI, 0.25 to
0.22; P<0.001) had a greater prevalence of hypertension.
Once we adjusted the models for these 3 confounding
factors (poverty, ethnicity, and education), there were still
positive and signiﬁcant associations between adjusted mor-
tality attributable to CVD (b=1.2; 95% CI, 1.0–1.4; P<0.001;
Table 2) and stroke (b=1.1; 95% CI, 0.77–1.3; P<0.001;
Table 2) and the PM2.5 level. Finding suggested that increases
in the levels of PM2.5 air pollution by 5 lg/m
3 were
associated with increases in the mortality from CVD by only
6 people per 100 000 population (0.12%) and from stroke by
5.5 people per 100 000 population (6.8%). Although these
mortalities appear small when multiplied by the adult
population of the United States that they refer to, they
amount to 1125 and 1375 deaths per annum from CVD and
stroke, respectively. In addition, the association between
prevalence of hypertension and PM2.5 remained signiﬁcant
after we took account of these confounding factors (b=0.18;
95% CI, 0.16–0.20; P<0.001; Table 2). The b values suggest
that an increase in PM2.5 air pollution by 5 lg/m
3 was
associated with a 0.9% increase in the prevalence of
hypertension.
In the crude model, there was a positive association
between ozone (mean, 0.073 ppm) levels and CVD mortality
(Table 2). The b values suggested that increases in the levels
of ozone air pollution by 0.01 ppm (a 13% increase relative to
mean levels) would be associated with increases in the
mortality from CVD by 13.7 people per 100 000 population
(3.7% increase on mean levels). For hypertension prevalence,
the b values indicate that an increase in ozone air pollution by
0.01 ppm was associated with a 0.25% increase in hyperten-
sion. After adjustment for poverty, ethnicity, and education,
the association between CVD mortality and ozone remained
(b=21.8; 95% CI, 15.7–28.0; P<0.001; Table 2). However, the
link between hypertension prevalence and ozone was no
longer signiﬁcant (b=5.09; 95% CI, 2.4 to 12.4; P=0.183;
Table 2). No signiﬁcant association between ozone concen-
tration and stroke mortality in either the crude or adjusted
model was observed (P>0.101, Table 2). To determine the
joint impact of PM2.5 and ozone, we included both of them as
independent predictors in a multiple linear regression
(collinearity checked). For CVD mortality (adjusted for
poverty, ethnicity, and education), both ozone and PM2.5
Table 1. Distribution of Dependent and Independent
Variables
Variables Value, MeanSD No. of Counties
PM2.5, lg/m
3 11.91.7 3111
Ozone, ppm 0.060.01 801
CVD mortality,
per 100 000 population
362.982.8 3134
Stroke mortality,
per 100 000 population
79.916.2 3119
Obesity by body
mass index, kg/m2
30.84.5 3143
Poverty, % 16.86.4 3159
Education, % 20.18.9 3160
CVD indicates cardiovascular disease; and PM2.5, particulate matter with diameters
<2.5 lm.
Table 2. Details of the Association Between PM2.5 and Ozone With Mortality From CVD and Stroke and Prevalence of
Hypertension in Both Crude and Adjusted Models
Outcomes
PM2.5 Ozone
b 95% CI P Value b 95% CI P Value
Crude model CVD mortality 15.4 13.7 to 17.0 <0.001 1372.1 859.1 to 1888.9 <0.001
Stroke mortality 2.7 2.41 to 3.05 <0.001 88.3 17.3 to 194.0 0.101
Hypertension prevalence 0.0086 0.0079 to 0.0092 <0.001 0.25 0.19 to 0.49 0.034
Adjusted model CVD mortality 1.2 1.0 to 1.4 <0.001 21.8 15.7 to 28.0 <0.001
Stroke mortality 1.1 0.77 to 1.3 <0.001 4.90 1.6 to 11.4 0.143
Hypertension prevalence 0.18 0.16 to 0.20 <0.001 5.09 2.4 to 12.4 0.183
Simple and multivariate linear regression applied. Adjusted model: adjusted for poverty, ethnicity, and education. CVD and stroke mortality (per 100 000 population), ozone concentration
(ppm), PM2.5 concentration (lg/m
3). CI indicates conﬁdence interval; CVD, cardiovascular disease; and PM2.5, particulate matter with diameters <2.5 lm.
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were signiﬁcant independent factors with no signiﬁcant
interaction (pooled R2=0.111; for PM2.5: b=0.12; 95% CI,
0.085–0.156; P<0.001; for ozone: b=13.3; 95% CI, 6.7–19.4;
P<0.001; P=0.117 for interaction; Table 3).
We also determined the relationships between mortality
from CVD and stroke at different prevalences of obesity
(Figure 1A through 1D). In the crude model for CVD mortality,
when the concentration of PM2.5 changed from low
(meanSD, 10.2 lg/m3) to high (mean+SD, 13.6 lg/m3),
the rate of mortality in the low obesity prevalence areas
(prevalence, 26.2%) changed from 309.7 to 325.8 deaths per
100 000 individuals per annum (an increase of 16.1).
However, at the high prevalence of obesity (35.3%), it changed
from 383.7 to 430.4 deaths per 100 000 individuals per year
(an increase of 46.7 deaths per annum), suggesting obesity
strongly modulates the impact of PM2.5 on CVD mortality
(Figure 1A). This impact was robust even after adjustment for
poverty, ethnicity, and education. As the concentration of
PM2.5 changed from low to high, in low obesity prevalence
regions, CVD mortality changed from 332.1 to 353.3 deaths
(per 100 000 individuals per annum; 21.1 increase), and it
changed from 369.0 to 401.1 deaths (per 100 000 individuals
per annum; 32.1 increase) for counties with a high obesity rate
(Figure 1B). In the same analysis for stroke mortality, when
the concentration of PM2.5 changed from low (10.2 lg/m
3) to
high (13.6 lg/m3), rate of the mortality in the low obesity
category (26.2%) changed from 70.9 to 74.6 deaths per
100 000 individuals per annum (an increase of 3.7); however,
at the high prevalence of obesity (35.3%), it increased from
82.3 to 90.8 deaths per 100 000 individuals per annum (an
increase of 8.5). Hence, obesity prevalence also had a strong
modulating effect on the impact of PM2.5 on stroke mortality
(Figure 1C). Once we adjusted the model for poverty,
ethnicity, and education, we found for stroke mortality, when
the concentration of PM2.5 changed from low to high rate, the
mortality in the low obesity category changed from 74.7 to
78.8 deaths per 100 000 individuals per annum (an increase
of 4.1); however, at the high prevalence of obesity, it
increased from 80.4 to 85.7 deaths per 100 000 individuals
per annum (an increase of 5.3). In Figure 2A and 2B,
3-dimensional plots illustrating the impact of obesity on the
link between CVD and stroke mortality with PM2.5 are
presented.
In the mediation analysis, we used 2 separate models for
mortality from CVD and stroke (adjusted for poverty, educa-
tion, and ethnicity). This analysis suggested that hypertension
partially mediates the association between PM2.5 and CVD
mortality (action theory, 0.0029; conceptual theory, 1204.4;
direct effect, 5.24; total effect, 8.7; proportion of mediation,
40.1%; all P<0.001) and stroke mortality (action theory,
Table 3. Details of the Analysis for Multiple Regression Models
Models Equation t Value P Value Collinearity Test (VIF) R2
1 Crude CVD mortality vs
ozone and PM2.5
Ozone y=404X1+13.7X2+143.0 1.1 0.240 0.87 0.143
PM2.5 9.0 <0.001 0.87
Interaction 3.7 <0.001 0.98
2 Stroke mortality vs
ozone and PM2.5
Ozone y=92.3X1+2.29X2+46.1 2.0 0.045 0.87 0.131
PM2.5 9.5 <0.001 0.87
Interaction 3.2 <0.001 0.98
3 Hypertension prevalence
vs ozone and PM2.5
Ozone y=0.25X1+0.007X2+0.314 2.4 0.016 0.87 0.153
PM2.5 10.4 <0.001 0.87
Interaction 4.3 <0.001 0.98
4 Adjusted CVD mortality vs ozone
and PM2.5
Ozone y=13.7X1+0.123X22.43 3.9 <0.001 0.87 0.111
PM2.5 6.6 <0.001 0.87
Interaction 1.5 0.117 0.98
5 Stroke mortality vs
ozone and PM2.5
Ozone y=2.44X1+0.135X21.57 0.8 0.379 0.87 0.071
PM2.5 6.9 <0.001 0.87
Interaction 2.2 0.026 0.98
6 Hypertension prevalence
vs ozone and PM2.5
Ozone y=6.85X1+0.172X21.73 1.9 0.054 0.87 0.084
PM2.5 7.7 <0.001 0.87
Interaction 3.3 0.018 0.98
Multiple linear regressions conducted. Adjusted model is corrected for poverty, ethnicity, and education. X1=ozone concentration (ppm), X2=PM2.5 concentration (lg/m
3), CVD, and stroke
mortality (per 100 000 population). CVD indicates cardiovascular disease; PM2.5, particulate matter with diameters <2.5 lm; and VIF, variance inﬂation factor.
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0.0029; conceptual theory, 195.9; direct effect, 0.92; total
effect, 1.4; proportion of mediation, 38.2%; all P<0.001).
Discussion
In the current study, we aimed to evaluate the spatial
association between several disease outcomes, speciﬁcally
mortality from CVD and stroke, and the prevalence of
hypertension, and the long-term exposure levels of PM2.5 and
ozone. Using this large nationwide survey population (>3100
US counties representing >170 million individuals), we found
that the counties with higher levels of air pollution (PM2.5) had
greater risk of mortality from CVD and stroke; also, individuals
living in these areas were more likely to have hypertension.
These associations were much reduced in effect size, but
remained signiﬁcant after adjustment for potential confounding
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Figure 1. Impact of the variable level of obesity prevalence on the link between particulate matter with diameters <2.5 lm (PM2.5) and
cardiovascular disease (CVD) and stroke mortality in crude and adjusted models. A, Crude model of impact of different level of obesity on the
association between CVD mortality and PM2.5 level (lg/m
3). B, Adjusted model (ethnicity, poverty, and education) of impact of different level of
obesity on the association between CVD mortality and PM2.5 level. C, Crude model of impact of different level of obesity on the association
between stroke mortality and PM2.5 level. D, Adjusted model (ethnicity, poverty, and education) of impact of different level of obesity on the
association between stroke mortality and PM2.5 level. AO indicates average obesity; APM, average PM2.5; HO, high obesity; HPM, high PM2.5; LO,
low obesity; and LPM, low PM2.5.
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factors, including poverty, ethnicity, and education. We have
also found the link between ozone and CVD mortality in both
the crude and adjusted model; however, no association
remained between hypertension prevalence and ozone levels,
once we adjusted the model for poverty, ethnicity, and
education. In a multiple pollutant model, PM2.5 and ozone were
independent risk factors for CVD mortality. Moreover, in areas
with higher rates of obesity, PM2.5 had a more deleterious
impact on both CVD and strokemortality. This effect was robust
after adjustment for potential confounders. Using counterfac-
tual mediation analysis, we showed that the association
between PM2.5 and both CVD and stroke mortality was partially
mediated by the association between PM2.5 and hypertension.
These data conﬁrm the 2009 scientiﬁc statement of the
American Heart Association on PM and CVD.5
Cardiovascular Disease
The present results were in line with other studies that have
suggested the level of long-term exposure to PM2.5 is
associated with higher risk of CVD.5,13,20,21,48–53 For example,
using a much smaller sample of 106 US counties, a positive
and signiﬁcant association was observed between long-term
county-speciﬁc estimates of PM2.5 and cardiovascular
hospitalizations.49 Another study using data from 6 US cities
(n=8111 adults) concluded that long-term air pollution
contributes to excess mortality.54 Several time series studies,
speciﬁcally the National Morbidity, Mortality and Air Pollution
Study (long-term) and the Air Pollution and Health: A
European Approach (short-term), have shown that temporal
variations in PM2.5 were signiﬁcantly associated with daily all-
cause and CVD death.55,56
In contrast, a large cohort study (22 European cohort
studies; total population, 367 383 participants, with 9994
deaths from CVD) failed to ﬁnd any association between long-
term PM2.5 exposure and CVD death.
13 The authors reported
that this negative ﬁnding could be attributable to relying on
data from mortality registries; there may be coding differ-
ences in death certiﬁcates among countries and among
ESCAPE areas. Moreover, they applied land-use regression
models used for exposure assessment, which were based on
air pollution measurements from 2008 to 2011, whereas the
cohort studies included in ESCAPE started much earlier
(1985–2007, with most studies starting in the mid-1990s).13
In another study (combining 22 European cohort studies), the
total study population consisted of 367 251 participants who
contributed 5 118 039 person-years at risk (average follow-
up, 13.9 years), of whom 29 076 died from natural causes
during follow-up.15 Despite this large sample, they failed to
ﬁnd any association between long-term PM2.5 exposure and
CVD death.15 Again, a negative result in this study could be
because of the discrepancy in timing between the data
collection for disease risk and pollution measures. Data
collection for some of these large European cohorts began in
1985 before air pollution monitoring networks were widely
established; air pollution was measured between 2008 and
2011. The authors extrapolated exposures for each cohort
back to the start of the study period and, therefore, exposure
misclassiﬁcation might have occurred. Pooled individual
patient data were not available in this analysis, which limited
the power of the study to assess heterogeneity and suscep-
tibility across different risk groups and regions.15
Some plausible pathophysiological mechanisms have been
suggested for the harmful effects of PM2.5 on health. Both
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Figure 2. Plots (3 dimensional) of the association between particulate matter with diameters <2.5 lm (PM2.5) and obesity with either
cardiovascular disease (CVD) or stroke mortality. A, Association between PM2.5 and obesity with CVD mortality. B, Association between PM2.5
and obesity with stroke mortality.
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animal and human experiments have reported that exposure to
PM2.5 may cause inﬂammation of the respiratory system; in
particular, exposure to PM2.5 may result in elevated
systemic inﬂammation and an increased risk of cardiovascular
stress.57–60 It has been suggested that, in humans, exposure to
air pollution can lead to increased levels of interleukin 6 and can
increase the production of C-reactive protein, which is known
as an independent risk factor for CVD.61 Each 100-lg/m3
increase in PM2.5 was suggested to increase the C-reactive
protein by 8.1 mg/L.62 Human studies have also reported
microRNAs, which are involved in the processes of systemic
inﬂammation, endothelial dysfunction, and atherosclerosis,
might be stimulated by PM2.5.
63 Exposing mice to PM2.5
(143.8 lg/m3) for 6 hours showed that there was elevated
gene expression of inﬂammation-related genes, such as tumor
necrosis factor-a, tumor necrosis factor-b, interleukin 6, and
interleukin 8.64 It is well established that increased levels of
proinﬂammatory cytokines and proinﬂammatory mediators
(tumor necrosis factor-a, tumor necrosis factor-b, interleukin 6,
and interleukin 8) are closely related to increased blood
coagulability, leading to endothelial dysfunction.59,65
We found there was a strong modulating effect of the level
of obesity on the relationship between CVD and PM2.5.
Similarly, a cross-sectional study of Chinese adults
(n=24 845, aged 18–74 years) reported that being overweight
and obese may enhance the effects of air pollution on the
prevalence of CVDs and stroke in northeastern metropolitan
China.30 Furthermore, in another study between adults in
eastern Massachusetts, it has been reported that there are
greater autonomic cardiac responses to PM2.5 in obese
workers, supporting the hypothesis that obesity may impart
greater susceptibility to acute cardiovascular effects of ﬁne
particles.66 A prevalence of obesity 1 SD above the average
resulted in the impact of PM2.5 being 39 greater than in areas
where the prevalence of obesity was 1 SD below average. In
the adjusted models, 1 SD higher than the mean prevalence
of obesity resulted in higher rate of CVD mortality rate (in
same level of PM2.5). The mechanism for this association
remains uncertain at present, but because obesity is a low-
grade inﬂammatory state, this may interact with the inﬂam-
matory effects of PM2.5 previously detailed above (see more
detailed discussion later under stroke). More physiological
studies on the different responses of obese and lean
individuals exposed to different levels of PM2.5 are required
to better understand this effect. Consistent with Brook et al,5
we found no evidence of any nonlinearity in the response,
suggesting no lower safe limit for long-term exposure.
Stroke
In accord with several previous studies, people living in the
areas with higher levels of the PM2.5 had elevated risk of
stroke mortality. Previous studies reported that a 10-lg/m3
increase in short-term PM2.5 concentration may be associated
with a 1% to 5% increase in the likelihood of stroke.21,23,67 In
review articles, it has been proposed that increased inﬂam-
mation, vascular reactivity, and endothelial dysfunction might
be reasons for the underlying impact of PM2.5 on stroke.
64,68
The Dijon Stroke Register in France reported that long-term
PM2.5 exposure was most strongly associated with strokes
caused by cardiometabolic risk factors, which indicated an
indirect impact of the PM2.5 on stroke incidence.
24
An earlier study has suggested that even in developed
countries, where annual mean air pollution concentrations
meet current international standards, small (5-lg/m3)
increases in long-term PM2.5 concentration were linked with
a 19% increase in the risk of stroke.69 Our results on long-
term PM2.5 exposure for comparison suggested that each
5-lg/m3 increase in PM2.5 leads to 52% increase in
likelihood of stroke (adjusted for poverty, education, and
ethnicity) and, therefore, support these previous data. In
another study, it has been suggested that short-term
increases of 3.0 lg/m3 in PM2.5 levels are associated with
changes in cerebrovascular hemodynamics, including
increased cerebrovascular resistance and reduced cerebral
blood ﬂow.70
We found there was a strong modulating effect of the level
of obesity on the relationship between stroke and PM2.5. A
prevalence of obesity 1 SD above the average resulted in the
impact of PM2.5 being 39 greater than in areas where the
prevalence of obesity was 1 SD below average. In the
adjusted models, 1 SD higher than means for obesity
resulted in higher rate of stroke mortality rate (in same level
of PM2.5). A handful of previous studies have addressed the
impact of obesity on the association between PM2.5 and CVD
and stroke. For example, 2 cohort (long-term exposure)
studies in women have shown that a greater BMI enhances
the susceptibility for PM-induced CVD mortality10,71; how-
ever, they have indicated that their ﬁndings need to be
conﬁrmed by other studies.10,71 Another study concerned the
impact of short-term air pollution exposure on C-reactive
protein, as an independent risk factor for CVD; the authors
have reported that the associations between air pollution
exposure and C-reactive protein were strongest and most
consistent for the 14 individuals with obesity.72 Another
study aimed to evaluate whether and to what extent obesity
can affect relationships between long-term PM2.5 exposure
and BP. The authors have reported positive associations
between PM2.5 exposure and BP; however, they suggested
that it was more visible and consistent among those who
were obese.73 Possibly, obese subjects have higher level of
oxidative stress and reactive oxygen species production,74
which may lead to CVD and stroke mortality.75 Another
possible pathway includes the association of obesity with
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established CVD risk factors (eg, metabolic syndrome,
enhanced insulin resistance, and hyperglycemia) that are
cumulatively damaging to the endothelium,76 and risk factors
as potential modulators of the endothelial phenotype in obesity,
including oxidative stress74 and chronic inﬂammation.77,78 In
this case, our ﬁndings suggested that in areas with higher
prevalence of obesity, the population may be at increased
likelihood of CVD and stroke morbidity associated with ambient
air pollution.
Hypertension and Mediation of the CVD and
Stroke Effects
We found that there was an association between higher
concentrations of the PM2.5 and greater risk of hypertension.
There are relatively few previous studies in the United
States,79–87 and in these studies, there was consensus that
BP increased after exposure (both long- and short-term) to
PM2.5.
79–87 However, most of these studies have low sample
size (n<500),79–84,86,87 with just 1 study on a population of
>5000 individuals with short-term exposure.85 In another
study, it was reported that short-term PM2.5 exposure leads to
no changes in BP.88 However, it has been suggested that the
lack of statistical signiﬁcance of the BP elevation in this study
was most probably explained by an inadequate sample size
and, hence, low power.88
In an incidence study of 3236 black women in Los Angeles,
CA, it was reported that when long-term PM2.5 exposure was
analyzed separately, the incidence rate ratio for hypertension
for a 10-lg/m3 increase was 1.48 (95% CI, 0.95–2.31).89
Results from the MESA (Multi-Ethnic Study of Atherosclerosis)
showed that systolic BP was positively associated with short-
term PM2.5 exposure. A 10-mg/m
3 increase in PM2.5 for 30
days was associated with 1.12–mm Hg higher pulse pressure
and 0.99–mm Hg higher systolic BP.85 A recent meta-analysis
that included 22 studies suggested that BP was positively
related to PM2.5 exposure, with an elevation of 1.39 mm Hg
(95% CI, 0.874–1.912 mm Hg) and 0.89 mm Hg (95% CI,
0.49–1.299 mm Hg) per 10-lg/m3 increase for systolic BP
and diastolic BP, respectively.90 A small study of normoten-
sive, nonsmoking, healthy adults (n=23) suggested that short-
term exposure to PM2.5 signiﬁcantly increased the diastolic
BP.91
In the current study, the link between CVD and stroke
mortality and long-term PM2.5 level was affected by hyper-
tension. In this regard, 2 links in the pathway are important.
First, there is an association between hypertension and
mortality from CVD and stroke, which is well known.92,93
Second, there is an association between PM2.5 concentration
and hypertension, which was previously reviewed. Several
possible biological mechanisms could be responsible for the
association between airborne PM and BP. Studies revealed
that PM2.5 may lead to elevated production of reactive oxygen
species, resulting in oxidative stress and systemic inﬂamma-
tion, which can result in damage to NO-dependent vascular
dilation and increasing vasoconstrictor in ex vivo and in vivo
experiments.5,94–96 As another possible biological mecha-
nism, there is positive association between endothelin-1, a
putative potent endogenous vasoconstrictor that causes
vascular endothelial dysfunction, and PM2.5.
97–99 However,
it is suggested that the main and most prominent route for
impact of PM2.5 on vascular function is via downregulation of
NO production.100 Exposure to PM2.5 can prevent endogenous
NO synthesis.100 Decreased bioavailability of NO not only can
lead to elevated BP but also increases the instability of BP,
which itself is considered a risk factor for CVD.100 Systemic
inﬂammation and vascular dysfunction might explain the
longer cumulative PM2.5 effects on BP. Moreover, the
autonomic nervous system is involved in the regulation of
BP, and the activation of the sympathetic nervous system
plays an important role in the upregulation of BP.
Impact of Ozone
In line with some previous studies, we found that ozone is a
likely risk factor for CVD. For example, a short-term increase
in ozone was associated with acute coronary events in
middle-aged adults with no preexisting CVD.101 Moreover, in
another study, short-term exposure to ozone was associated
with out-of-hospital cardiac arrest.102 In the case of stroke,
some studies reported an increased risk of stroke after a
short-term increase in ozone,103 whereas some investiga-
tions did not ﬁnd any association,104 which is in line with the
long-term (absence of) effects in our study. Moreover, a
recent meta-analysis and systematic review reported no
evidence of associations between long-term annual ozone
concentrations and the risk of death from CVD.29 In another
study that used data from the study cohort of the American
Cancer Society CPS II (Cancer Prevention Study II), it was
reported that ozone and PM2.5 single-pollutant models were
associated with CVD, whereas in contrast with our ﬁndings,
where signiﬁcant independent effects persisted, once PM2.5
and ozone were included in a multiple regression model, the
correlation with ozone disappeared.105 However, the authors
reported high collinearity between the concentrations of
ozone and PM2.5, and they stated that the effects of ozone
could, therefore, be confounded by the presence of PM2.5
because of this collinearity.105 In another study, short-term
ozone exposure was linked to BP.106 Moreover, 2 previous
studies found that ozone exposure was negatively (beneﬁ-
cially) or not associated with BP,80,107 but a recent study has
reported a positive association between ozone and both
systolic and diastolic BP measurements at slightly higher
exposure concentrations.108
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Limitations and Strengths
The ﬁndings of the present study should be considered in the
context of some clear limitations. First, the results were based
on a cross-sectional ecological study, and although it is
nationally representative, and well powered, this type of
design cannot demonstrate causality in the associations. We
took account of what we considered were likely to be the
most important confounding factors. However, there may be
other factors that are also important that we did not account
for, such as physical activity levels, which may in theory be
depressed at high levels of air pollution. However, a study
performed on Han Chinese, living in Beijing at high levels of air
pollution, found no link between PM2.5 levels and objectively
measured physical activity levels,109 perhaps indicating
physical activity is not normally depressed by air pollution,
particularly at the much lower levels involved in the current
study. Another limitation is that we had no data on other
sources of air pollution, such as PM with diameters <10 lm,
NO, and sulfur dioxide levels, which may covary with PM2.5
levels.5 Hence, any one of these additional sources of
pollution may be the ultimate causal factor. Although the
sources of data that we applied for current study were all
independent government institutions, some of the data are
potentially prone to error (eg, the measures of obesity [BMI]
were based on self-reported heights and weights). To end this,
we recommend in the future study to take account of sex and
age for analysis.
Although our analysis was not based on individual data, we
had a large sample, which included individuals selected by
“disproportionate stratiﬁed sampling,” and, therefore, the
results obtained from these nationally representative samples
can be extrapolated to the general population. Moreover, the
Behavioral Risk Factor Surveillance System is largest study of
its kind in United States and covers a comprehensive
geographic area. Furthermore, 1 of the reported weaknesses
of previous studies was the criteria and procedures used to
measure the PM2.5. However, in the current study, the data on
PM2.5 originated from US National Aeronautics and Space
Administration, which has highly validated and accurate
database.42 The data sources we used as covariates were
all ultimately derived from well-established and respected US
government departments, including the US Census.
Conclusion
Spatial variation in long-term exposure to PM2.5 across the
United States was associated with increased risk of both CVD
and stroke mortality. Ozone was an independent risk factor
for CVD. The effect of PM2.5 on CVD and stroke was
substantially modulated by the level of obesity, being 39
higher for CVD and 29 higher for stroke, in areas with high
compared with low obesity levels. Moreover, areas with
increased PM2.5 concentrations had populations with a
markedly higher level of hypertension. Our analysis suggested
that hypertension has an indirect effect on the link between
CVD and stroke mortality with PM2.5.
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